欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1608/002
药品名称
Everolimus Teva
活性成分
everolimus 5.0 mg
剂型
Tablet
上市许可持有人
Teva Sweden AB Box 1070 251 10 Helsingborg Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Everolimus-ratiopharm 5 mg Tabletten
Denmark (DK)
Netherlands (NL)
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Everolimus ratiopharm 5 mg Tabletten
France (FR)
Portugal (PT)
Greece (GR)
EVEROLIMUS/TEVA
Norway (NO)
Everolimus Teva
Czechia (CZ)
Everolimus Teva 5 mg tablety
Slovakia (SK)
Everolimus Teva 5 mg
Croatia (HR)
Everolimus Pliva 5 mg tablete
许可日期
2017/05/03
最近更新日期
2024/05/23
药物ATC编码
L01EG02 everolimus
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR Summary
|
SE/H/1608/002_PAR Summary
Date of last change:2017/09/19
PAR
|
SE/H/1608/002_PAR
Date of last change:2017/09/19
Final PL
|
SE/H/1608/002_Final PL
Date of last change:2017/08/30
Final SPC
|
SE/H/1608/002_Final SPC
Date of last change:2017/08/30
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase